Literature DB >> 2387092

Recognition of synthetic peptides of Sm-D autoantigen by lupus sera.

S Barakat1, J P Briand, J C Weber, M H van Regenmortel, S Muller.   

Abstract

The reactivity of autoantibodies present in the serum of patients with systemic lupus erythematosus (SLE) was investigated by ELISA using seven overlapping synthetic peptides representing the entire sequence of the polypeptide D component of 'Sm antigen'. Of the 165 SLE sera tested, 59% were found to contain IgG antibodies able to bind to peptide 1-20, while 37% of the sera reacted with peptide 44-67. All sera reacting with peptide 44-67 also reacted with peptide 1-20. These two peptides were only seldom recognized by the sera of 187 patients with other rheumatic autoimmune diseases or by 53 sera of normal individuals. In a parallel study using sera that reacted with the D band in immunoblotting, most of the sera recognized peptides 44-67 (89%) and 1-20 (67%), while 33% of them reacted with peptide 97-119. The use of these synthetic peptides in ELISA may be of considerable help for detecting anti Sm autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2387092      PMCID: PMC1535060          DOI: 10.1111/j.1365-2249.1990.tb03327.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Primary structure of a human small nuclear ribonucleoprotein polypeptide as deduced by cDNA analysis.

Authors:  L A Rokeach; M Jannatipour; J A Haselby; S O Hoch
Journal:  J Biol Chem       Date:  1989-03-25       Impact factor: 5.157

2.  Molecular cloning of the cDNA for the human U2 snRNA-specific A' protein.

Authors:  P T Sillekens; R P Beijer; W J Habets; W J van Verooij
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

3.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

4.  Prediction of protein antigenic determinants from amino acid sequences.

Authors:  T P Hopp; K R Woods
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

5.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

6.  Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides.

Authors:  S Muller; D Bonnier; M Thiry; M H Van Regenmortel
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

7.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

8.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  Preparative isolation of p67, A, B, B' and D from nRNP/Sm and Sm antigens by reverse-phase chromatography. Use in a polypeptide-specific ELISA for independent quantitation of anti-nRNP and anti-Sm antibodies.

Authors:  D G Williams; P J Charles; R N Maini
Journal:  J Immunol Methods       Date:  1988-10-04       Impact factor: 2.303

10.  A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies.

Authors:  S Plaué; S Muller; M H van Regenmortel
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  16 in total

1.  Analysis of the autoimmune epitopes on human testicular NASP using recombinant and synthetic peptides.

Authors:  I N Batova; R T Richardson; E E Widgren; M G O'Rand
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.

Authors:  S Barakat; O Meyer; F Torterotot; P Youinou; J P Briand; M F Kahn; S Muller
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

Review 3.  B-cell epitopes of Sm autoantigens.

Authors:  L A Rokeach; S O Hoch
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 4.  Methods of epitope mapping.

Authors:  I Pettersson
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 5.  Protein antigenicity.

Authors:  M H Van Regenmortel
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 6.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

Review 7.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

8.  Mapping of epitopes on U1 snRNP polypeptide A with synthetic peptides and autoimmune sera.

Authors:  S Barakat; J P Briand; N Abuaf; M H van Regenmortel; S Muller
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  New Zealand white rabbits immunized with RNA-complexed total histones develop an autoimmune-like response.

Authors:  C Atanassov; J P Briand; D Bonnier; M H Van Regenmortel; S Muller
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

10.  A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus.

Authors:  G Riemekasten; J Marell; G Trebeljahr; R Klein; G Hausdorf; T Häupl; J Schneider-Mergener; G R Burmester; F Hiepe
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.